Phenytoin versus levetiracetam as prophylaxis for postcraniotomy seizure in patients with no history of seizures: systematic review and meta-analysis

被引:6
|
作者
Lee, Chang-Hyun [1 ]
Koo, Hae-Won [3 ]
Han, Seong Rok [2 ]
Choi, Chan-Young [2 ]
Sohn, Moon-Jun [3 ]
Lee, Chae-Heuck [2 ]
机构
[1] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea
[2] Inje Univ, Coll Med, Dept Neurosurg, Ilsan Paik Hosp, Goyang, South Korea
[3] Inje Univ, Ilsan Paik Hosp, Dept Neurosurg, Neurosci & Radiosurg Hybrid Res Ctr,Coll Med, Goyang, South Korea
关键词
levetiracetam; phenytoin; seizure; de novo; craniotomy; brain tumor; epilepsy; BRAIN-TUMOR SURGERY; ANTICONVULSANT PROPHYLAXIS; POSTOPERATIVE SEIZURES; CRANIOTOMY; SAFETY; PREVENTION; TOLERABILITY; EFFICACY; DRUGS;
D O I
10.3171/2018.4.JNS1891
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE De novo seizure following craniotomy (DSC) for nontraumatic pathology may adversely affect medical and neurological outcomes in patients with no history of seizures who have undergone craniotomies. Antiepileptic drugs (AEDs) are commonly used prophylactically in patients undergoing craniotomy; however, evidence supporting this practice is limited and mixed. The authors aimed to collate the available evidence on the efficacy and tolerability of levetiracetam monotherapy and compare it with that of the classic AED, phenytoin, for DSC. METHODS PubMed, Embase, Web of Science, and the Cochrane Library were searched for studies that compared levetiracetam with phenytoin for DSC prevention. Inclusion criteria were adult patients with no history of epilepsy who underwent craniotomy with prophylactic usage of phenytoin, a comparator group with levetiracetam treatment as the main treatment difference between the two groups, and availability of data on the numbers of patients and seizures for each group. Patients with brain injury and previous seizure history were excluded. DSC occurrence and adverse drug reaction (ADR) were evaluated. Seizure occurrence was calculated using the Peto odds ratio (POR), which is the relative effect estimation method of choice for binary data with rare events. RESULTS Data from 7 studies involving 803 patients were included. The DSC occurrence rate was 1.26% (4/318) in the levetiracetam cohort and 6.60% (32/485) in the phenytoin cohort. Meta-analysis showed that levetiracetam is significantly superior to phenytoin for DSC prevention (POR 0.233, 95% confidence interval [CI] 0.117-0.462, p < 0.001). Subgroup analysis demonstrated that levetiracetam is superior to phenytoin for DSC due to all brain diseases (POR 0.129, 95% CI 0.039-0.423, p = 0.001) and tumor (POR 0.282, 95% CI 0.117-0.678, p = 0.005). ADRs in the levetiracetam group were cognitive disturbance, thrombophlebitis, irritability, lethargy, tiredness, and asthenia, whereas rash, anaphylaxis, arrhythmia, and hyponatremia were more common in the phenytoin group. The overall occurrence of ADR in the phenytoin (34/466) and levetiracetam (26/432) groups (p = 0.44) demonstrated no statistically significant difference in ADR occurrence. However, the discontinuation rate of AEDs due to ADR was 53/297 in the phenytoin group and 6/196 in the levetiracetam group (POR 0.266, 95% CI 0.137-0.518, p < 0.001). CONCLUSIONS Levetiracetam is superior to phenytoin for DSC prevention for nontraumatic pathology and has fewer serious ADRs that lead to discontinuation. Further high-quality studies that compare levetiracetam with placebo are necessary to provide evidence for establishing AED guidelines.
引用
收藏
页码:2063 / 2070
页数:8
相关论文
共 50 条
  • [21] Levetiracetam versus phenytoin as seizure prophylaxis in severe traumatic brain injury
    Jones, Kristen E.
    Puccio, Ava M.
    Hashman, Kathy J.
    Jankowitz, Brian T.
    Fischer, Michael
    Okonkwo, David O.
    [J]. JOURNAL OF NEUROTRAUMA, 2008, 25 (07) : 908 - 908
  • [22] Levetiracetam versus phenytoin as seizure prophylaxis in severe traumatic brain injury
    Jones, Kristen E.
    Puccio, Ava
    Harshman, Kathy J.
    Falcione, Bonnie
    Benedict, Neal
    Jankowitz, Brian T.
    Fischer, Michael R.
    Okonkwo, David O.
    [J]. NEUROSURGERY, 2008, 62 (06) : 1413 - 1414
  • [23] Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury
    Jones, Kristen E.
    Puccio, Ava M.
    Harshman, Kathy J.
    Falcione, Bonnie
    Benedict, Neal
    Jankowitz, Brian T.
    Stippler, Martina
    Fischer, Michael
    Sauber-Schatz, Erin K.
    Fabio, Anthony
    Darby, Joseph M.
    Okonkwo, David O.
    [J]. NEUROSURGICAL FOCUS, 2008, 25 (04)
  • [24] RETROSPECTIVE COMPARISON OF THE COST AND EFFECTIVENESS OF LEVETIRACETAM VERSUS PHENYTOIN FOR SEIZURE PROPHYLAXIS
    Johnson, Donald
    Rottman, Kathleen
    DeLosSantos, Marci
    Jacksonville, Shands
    [J]. CRITICAL CARE MEDICINE, 2009, 37 (12) : A475 - A475
  • [25] Levetiracetam versus phenytoin for the treatment of established status epilepticus: A systematic review and meta-analysis of randomized controlled trials
    Li, Linjie
    Zhang, Yu
    Jia, Lu
    Jia, Desheng
    Faramand, Andrew
    Chong, Weelic
    Fang, Yuan
    Ma, Lu
    Fang, Fang
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2020, 78 : 43 - 48
  • [26] The Prevalence of Seizures in Brain Metastasis Patients on Anticonvulsant Prophylaxis: A Systematic Review and Meta-Analysis
    Kermanshahi, Nazanin
    Hamidi, Nima
    Weisberg, Jake
    Beg, Usman
    Dabrowski, Michael
    Padmanaban, Varun
    Betz, Jeannette
    Mansouri, Alireza
    [J]. WORLD NEUROSURGERY, 2024, 183 : E613 - E624
  • [27] Efficacy and safety of levetiracetam for migraine prophylaxis in children: a systematic review and meta-analysis
    Peng, Jing
    Liu, Linhui
    Li, Qiaoling
    Liu, Maochang
    Zhou, Rong
    Chen, Li
    Liu, Zhisheng
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] Postoperative Seizure Prophylaxis in Meningioma Resection: A Systematic Review and Meta-Analysis
    Batista, Savio
    Bertani, Raphael
    Palavani, Lucca B.
    Oliveira, Leonardo de Barros
    Borges, Pedro
    Koester, Stefan W.
    Paiva, Wellingson Silva
    [J]. DIAGNOSTICS, 2023, 13 (22)
  • [29] Comparison of levetiracetam versus phenytoin/fosphenytoin for busulfan seizure prophylaxis at a pediatric institution
    Hughes, Kaitlynn
    Garrity, Lisa
    Nelson, Adam S.
    Lane, Adam
    Teusink-Cross, Ashley
    [J]. PEDIATRIC TRANSPLANTATION, 2021, 25 (04)
  • [30] Cognitive outcomes following seizure prophylaxis for intracranial hemorrhages with levetiracetam versus phenytoin
    Ehtisham, As'ad
    Taylor, Scott
    Klein, Michael W.
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (12) : A208 - A208